참고문헌
- Ajani JA, Mansfield PF, Janjan N, et al (2004). Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol, 22, 2774-80. https://doi.org/10.1200/JCO.2004.01.015
- Bittoni A, Faloppi L, Giampieri R, Cascinu S (2012). Selecting the best treatment for an individual patient. Recent Results Cancer Res, 196, 307-18. https://doi.org/10.1007/978-3-642-31629-6_20
- Blank S, Rachakonda S, Keller G, et al (2014). A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients. BMC Cancer, 14, 58. https://doi.org/10.1186/1471-2407-14-58
- Buergy D, Lohr F, Baack T, et al (2012). Radiotherapy for tumors of the stomach and gastroesophageal junction-a review of its role in multimodal therapy. Radiat Oncol, 7, 192. https://doi.org/10.1186/1748-717X-7-192
- Degiuli M, Sasako M, PontiA, Calvo F (2004). Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer, 90, 1727-32.
- Du CY, Chen JG, Zhou Y, et al (2012). Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer. World J Gastroenterol, 18, 3610-16. https://doi.org/10.3748/wjg.v18.i27.3610
- Edge S, Byrd DR, Compton CC,et al editors (2010). American Joint Committee on Cancer (AJCC). AJCC cancer staging manual, 7th edition. New York: Springer Verlag, 1-649.
- Ferlay J, Shin HR, Bray F, et al (2008). Estimates of worldwide burden of cancer in 2008: GLOBOCAN. Int J Cancer, 127, 2893-917.
- Garcia M, Ward EM, Center MM, et al (2008). Global Cancer Facts & Figures. 2007 [http://www.cancer.gov], [online]. Accessed Aug 20.
- Greenlee RT, Murray T, Bolden S, Wingo PA (2000). Cancer statistics. CA Cancer J Clin, 50, 7-33. https://doi.org/10.3322/canjclin.50.1.7
- Henning GT, Schild SE, Stafford SL, et al (2000). Results of irradiation or chemoirradiation Following resection of gastric adenocarcinoma. Int J Radiat Oncol Biol Phys, 46, 589-98. https://doi.org/10.1016/S0360-3016(99)00446-0
- Janunger KG, Hafstrom L, Glimelius B (2002). Chemotherapy in gastric cancer: A review and updated meta-analysis. Eur J Surg, 168, 597-608. https://doi.org/10.1080/11024150201680005
- Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300. https://doi.org/10.3322/caac.20073
- Jiang Y, Ajani JA (2010).Multidisciplinary management of gastric cancer. Curr Opin Gastroenterol, 26, 640-6. https://doi.org/10.1097/MOG.0b013e32833efd9b
- Klautke G, Foitzi T, Ludwig K, et al (2004). Neoadjuvant radiochemotherapy in locally advanced gastric carcinoma. Strahlenther Onkol, 180, 695-700. https://doi.org/10.1007/s00066-004-9194-z
- Kundel Y, Purim O, Idelevich E, et al (2011). Postoperative chemoradiation for resected gastric cancer-is the macdonald regimen tolerable? a retrospective multi-institutional study. Radiat Oncol, 6,127. https://doi.org/10.1186/1748-717X-6-127
- Lee WC, Yusof MM, Lau FN, Phua VC (2013). Preoperative long course chemoirradiation in a developing country for rectal carcinoma: Kuala Lumpur hospital experience. Asian Pac J Cancer Prev, 14, 3941-4. https://doi.org/10.7314/APJCP.2013.14.6.3941
- Liao Y, Yang ZL, Peng JS, Xiang J, Wang JP (2013). Neoadjuvant chemotherapy for gastric cancer: a meta-analysis of randomized, controlled trials. J Gastroenterol Hepatol, 28, 777-82. https://doi.org/10.1111/jgh.12152
- Mari E, Floriani I, Tinazzi A, et al (2000). Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomized trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomidell'Apparato Digerente). Ann Oncol, 11, 837-43. https://doi.org/10.1023/A:1008377101672
- Matsuda S, Takahashi T, Fukada J, et al (2014). Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-. Radiat Oncol, 9, 9. https://doi.org/10.1186/1748-717X-9-9
- Ott K, Sendler A, Becker K, et al (2003). Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study. Gastric Cancer, 6,159-67. P https://doi.org/10.1007/s10120-003-0245-4
- arkin DM, Ferlay J, Curado MP, et al (2010). Fifty years of cancer incidence: CI5 I-IX. Int J Cancer, 127, 2918-27. https://doi.org/10.1002/ijc.25517
- Patel SH, Kooby DA (2011). Gastric adenocarcinoma surgery and adjuvant therapy. Surg Clin North Am, 91, 1039-77. https://doi.org/10.1016/j.suc.2011.06.009
- Pepek JM, Chino JP, Willett CG, et al (2013). Preoperative chemoradiotherapy for locally advanced gastric cancer. Radiat Oncol, 8, 6. https://doi.org/10.1186/1748-717X-8-6
- Roshanaei G, Ghannad MS, Jafarabadi MA, Faradmal J, Sadighi S ( 2011). Prognostic impact of risk factors in patients with gastric cancer in Iran. Asian Pac J Cancer Prev, 12, 3005-8.
- Roth AD, Allal AS, Brundler MA, et al (2003). Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a phase I-II study. Ann Oncol, 14, 110-5. https://doi.org/10.1093/annonc/mdg023
- Sadighi S, Raafat J, Mohagheghi MA, Meemary F (2005). Gastric carcinoma: 5 year experience of a single institute. Asian Pac J Cancer Prev, 6, 195-6.
- Saghier AA, Kabanja JH, Afreen S, Sagar M (2013). Gastric Cancer: Environmental Risk Factors, Treatment and Prevention. J Carcinogene Mutagene, 14, 8.
- Shafaghi A, Mansour-Ghanaei F, Joukar F, et al (2013). Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions. Asian Pac J Cancer Prev, 14, 3931-6. https://doi.org/10.7314/APJCP.2013.14.6.3931
- Wang S, Zheng G, Chen L, Xiong B (2011). Effect of HER-2/neu Over-expression on prognosis in gastric cancer: a metaanalysis. Asian Pac J Cancer Prev, 12, 1417-23.
- Wilke H, Preusser P, Fink U, et al (1989). Preoperative chemotherapy in locally advanced and nonresectable gastric cancer. A phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol, 7, 1318-26.
- Wysocka B, Kassam Z, Lockwood G, et al (2010). Interfraction and respiratory organ motion during conformal radiotherapy in gastric cancer. Int J Rad Oncol Bio Phys, 77, 53-9. https://doi.org/10.1016/j.ijrobp.2009.04.046
피인용 문헌
- Proposal of a Nomogram for Predicting Survival in Patients with Siewert Type II Adenocarcinoma of the Esophagogastric Junction After Preoperative Radiation pp.1534-4681, 2019, https://doi.org/10.1245/s10434-019-07237-7